Reply: Low Prevalence of High On-Treatment Platelet Reactivity for Both Aspirin and Clopidogrel After HALT and TAVR

JACC Cardiovasc Interv. 2019 May 13;12(9):895-896. doi: 10.1016/j.jcin.2019.03.001.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aspirin*
  • Blood Platelets
  • Clopidogrel
  • Incidence
  • Prevalence
  • Transcatheter Aortic Valve Replacement*
  • Treatment Outcome

Substances

  • Clopidogrel
  • Aspirin